1 study found for:    15774791 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With Non-neuroblastoma, GD2+ Solid Tumors
Conditions: Sarcoma;   Osteosarcoma;   Rhabdomyosarcoma;   Ewing Sarcoma;   Melanoma
Interventions: Other: Anti-GD2.28.z.OX40.ICD9 (anti-GD2 CAR) retroviral transduced autologous peripheral Blood Lymphocytes);   Drug: AP1903 dimerizing agent

Indicates status has not been verified in more than two years